We Empower Providers to Expedite Access to Care
We are developing products that enable providers to reliably identify behavioral health conditions earlier and expedite access to treatments years earlier than today’s standard of care.
The Current System is Broken
The average age of an autism diagnosis has remained at 4.3 years of age for over 15 years. This means most children receive treatments after the critical early intervention window.
Cognoa Helps Providers Fill a Void in Care, Starting with Autism.
We are developing precision digital medicine devices that:
Are Clinically Validated
Validated through multiple robust clinical studies.
Increase Provider Efficiency
Reduces the time and steps needed to secure a diagnosis.
Easy to Implement
Fits into existing workflow. Ordered, dispensed and paid for utilizing existing healthcare infrastructure.
Our Lead Prescription
Digital
Medicine Products
CONDUCTING PIVOTAL STUDY
The First Digital
Diagnostic Aid for Autism
Currently in clinical trials, Cognoa’s ASD Diagnostic Device will help primary care providers to identify autism in children between the ages of 18 and 72 months of age.
How It Works
IN CLINICAL DEVELOPMENT
Digital Therapeutic
Designed for use at home with parents and used in conjunction with existing therapies, Cognoa’s ASD Therapeutic will help improve social-emotional reciprocity in children diagnosed with autism between the ages 3 and 7 years.
How it works
- Delivered via smart-phone
- Parent/child interact together
Prescribed Digital Medicines, Dispensed and Paid for, within the Existing Healthcare Infrastructure.
